TEAM

Who We Are

We have been investors and operators for decades.   Our experiences have led us to the simple belief that the combination of a powerful concept, a talented team, and access to expertise and capital can together bring vision to reality.  As our entrepreneurial partners can attest, we partner closely with them – lending our experience, knowledge and support to achieve their goals.

Learn More

FOCUS AREAS

Where We Invest

We invest in the realms we know best:  design and engineering software; Dartmouth College innovations; and the vibrant but underserved technology sector north of Boston.

Learn More

home_focus_areas

Who We Invest In

Borealis Ventures partners with exceptional entrepreneurs to build great companies from the earliest stages.

logo-newformalogo-fluxlogo-vetsfirstchoicelogo-adimablogo-flurrylogo-dyn

Learn More

Insights

Avedro Receives FDA Approval for Photrexa Viscous, Photrexa and the KXL System for Corneal Cross-Linking

April 18th, 2016|

Avedro, Inc., an ophthalmic pharmaceutical and medical device company, has received approval from the U.S. Food and Drug Administration (FDA) [...]

Mutant Yeast Are Cranking Out Pharma’s Next Superdrug

March 10th, 2016|

The offices of Adimab, a biotech company in Lebanon, New Hampshire, smell pleasantly of fresh bread. It’s an olfactory illusion, [...]

Adimab Announces Technology Transfer Agreement with Merck – Fourth Company to Internalize the Platform

January 12th, 2016|

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that [...]

See All